Skip to content

R&D at other companies

Abbott logo
AbbottABT
$767M+7.1%
DexCom logo
DexComDXCM
$145.3M+0.1%
Medtronic logo
MedtronicMDT
$671M-1.9%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$46.04M-8.3%
Embecta Corp. logo
Embecta Corp.EMBC
$5.4M-32.5%
Owlet logo
OwletOWLT
$3.96M+36.3%

Segments

By segment

See full
Single Reportable$8.61M+18.0%

Other financials

Income statement

See full
Revenue$11.7M+87.2%
Gross profit$6.9M+361%
Operating income-$31.8M-136%
Net income-$32.3M-127%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$29.6M-24.7%
Total debt$43.1M+5.0%
Total equity$34.3M-2.4%
Total assets$102.9M+17.9%

Cash flow

See full
Operating cash flow-$32.0M-99.2%
CapEx$111.0K-74.4%
Free cash flow-$32.1M-94.6%

Valuation

See full
Market cap$296.51M-21.4%
Enterprise value$310.04M-19.9%
P/S7.3×-7.5×

Profitability

See full
Gross margin52.1%+44.9pp
Operating margin-213%-46.7pp
Net margin-214.1%-51.2pp
FCF margin-186.4%-37.0pp

Returns & leverage

See full
Return on equity-250.7%-19.0pp
Debt / equity1.3×+0.1×
Current ratio3.5×-3.4×

Where this comes from

Reported directly by Senseonics Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Senseonics Holdings, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Senseonics Holdings, Inc. 's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Senseonics Holdings, Inc. 's R&D?
Senseonics Holdings, Inc. (SENS) reported R&D of $8.61M in Q1 2026.
How has Senseonics Holdings, Inc. 's R&D changed year-over-year?
Senseonics Holdings, Inc. 's R&D increased by 18.0% year-over-year, from $7.3M to $8.61M.
What is the long-term trend for Senseonics Holdings, Inc. 's R&D?
Over 4 years (2021 to 2025), Senseonics Holdings, Inc. 's R&D has grown at a 3.8% compound annual growth rate (CAGR), from $27.22M to $31.59M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.